NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

IO102-IO103 is an investigational off-the-shelf therapeutic cancer vaccine designed to kill both tumor cells ... The clinical trials are sponsored by IO Biotech and conducted in collaboration with ...

Havas Health has appointed Anna Maria Marra?as CEO of Europe to lead and oversee all aspects of the region's business operations.  Marra's prowess for overseeing cross-functional teams and driving ...

ScioSense today launched a two-channel time-to-digital converter (TDC) which offers the very high time measurement resolution ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Pfizer's stock underperforms the S&P 500, facing patent expirations and competition, yet offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker ...

Identifying stocks to buy and hold for decades rather than months or years can be difficult. The world and the economy are ...

The Middle East Veterinary Vaccine Market is poised for steady growth, with a projected market size of USD 627.1 million in 2023. The market is expected to expand at a CAGR of 4% through 2033, ...

"Receiving the RSV vaccine in pregnancy is an important way mothers can protect ... Inc. and is a consultant for and has ...